Acadian Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,864
| Closed | -$14K | – | 1796 |
|
|
2024
Q3 | $14K | Buy |
+1,864
| New | +$14K | ﹤0.01% | 2017 |
|
|
2023
Q1 | – | Sell |
-93,128
| Closed | -$324K | – | 1813 |
|
|
2022
Q4 | $324K | Buy |
+93,128
| New | +$324K | ﹤0.01% | 1158 |
|
|
2016
Q4 | – | Sell |
-2,866
| Closed | -$86K | – | 1666 |
|
|
2016
Q3 | $86K | Sell |
2,866
-1,314
| -31% | -$39.4K | ﹤0.01% | 1086 |
|
|
2016
Q2 | $118K | Sell |
4,180
-9,907
| -70% | -$280K | ﹤0.01% | 1004 |
|
|
2016
Q1 | $377K | Buy |
14,087
+5,389
| +62% | +$144K | ﹤0.01% | 797 |
|
|
2015
Q4 | $419K | Buy |
8,698
+3,177
| +58% | +$153K | ﹤0.01% | 841 |
|
|
2015
Q3 | $201K | Buy |
+5,521
| New | +$201K | ﹤0.01% | 903 |
|